1 Angiotensin Receptor Antagonists Market Overview 1.1 Product Overview and Scope of Angiotensin Receptor Antagonists 1.2 Angiotensin Receptor Antagonists Segment by Type 1.2.1 Global Angiotensin Receptor Antagonists Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Valsartan 1.2.3 Telmisartan 1.2.4 Losartan 1.2.5 Irbesartan 1.2.6 Azilsartan 1.2.7 Olmesartan 1.3 Angiotensin Receptor Antagonists Segment by Application 1.3.1 Global Angiotensin Receptor Antagonists Sales Comparison by Application: (2021-2027) 1.3.2 Hypertension 1.3.3 Cardiovascular Diseases 1.3.4 Kidney Diseases 1.3.5 Other 1.4 Global Angiotensin Receptor Antagonists Market Size Estimates and Forecasts 1.4.1 Global Angiotensin Receptor Antagonists Revenue 2016-2027 1.4.2 Global Angiotensin Receptor Antagonists Sales 2016-2027 1.4.3 Angiotensin Receptor Antagonists Market Size by Region: 2016 Versus 2021 Versus 2027 2 Angiotensin Receptor Antagonists Market Competition by Manufacturers 2.1 Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2016-2021) 2.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Angiotensin Receptor Antagonists Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Angiotensin Receptor Antagonists Manufacturing Sites, Area Served, Product Type 2.5 Angiotensin Receptor Antagonists Market Competitive Situation and Trends 2.5.1 Angiotensin Receptor Antagonists Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Angiotensin Receptor Antagonists Players Market Share by Revenue 2.5.3 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Angiotensin Receptor Antagonists Retrospective Market Scenario by Region 3.1 Global Angiotensin Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Angiotensin Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Angiotensin Receptor Antagonists Market Facts & Figures by Country 3.3.1 North America Angiotensin Receptor Antagonists Sales by Country 3.3.2 North America Angiotensin Receptor Antagonists Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Angiotensin Receptor Antagonists Market Facts & Figures by Country 3.4.1 Europe Angiotensin Receptor Antagonists Sales by Country 3.4.2 Europe Angiotensin Receptor Antagonists Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Angiotensin Receptor Antagonists Market Facts & Figures by Region 3.5.1 Asia Pacific Angiotensin Receptor Antagonists Sales by Region 3.5.2 Asia Pacific Angiotensin Receptor Antagonists Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Angiotensin Receptor Antagonists Market Facts & Figures by Country 3.6.1 Latin America Angiotensin Receptor Antagonists Sales by Country 3.6.2 Latin America Angiotensin Receptor Antagonists Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Angiotensin Receptor Antagonists Market Facts & Figures by Country 3.7.1 Middle East and Africa Angiotensin Receptor Antagonists Sales by Country 3.7.2 Middle East and Africa Angiotensin Receptor Antagonists Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Angiotensin Receptor Antagonists Historic Market Analysis by Type 4.1 Global Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021) 4.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2016-2021) 4.3 Global Angiotensin Receptor Antagonists Price by Type (2016-2021) 5 Global Angiotensin Receptor Antagonists Historic Market Analysis by Application 5.1 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021) 5.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2016-2021) 5.3 Global Angiotensin Receptor Antagonists Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Angiotensin Receptor Antagonists Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Novartis 6.2.1 Novartis Corporation Information 6.2.2 Novartis Description and Business Overview 6.2.3 Novartis Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Novartis Angiotensin Receptor Antagonists Product Portfolio 6.2.5 Novartis Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Merck Angiotensin Receptor Antagonists Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Astra Zeneca 6.4.1 Astra Zeneca Corporation Information 6.4.2 Astra Zeneca Description and Business Overview 6.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Astra Zeneca Angiotensin Receptor Antagonists Product Portfolio 6.4.5 Astra Zeneca Recent Developments/Updates 6.5 Jhonson and Johnson 6.5.1 Jhonson and Johnson Corporation Information 6.5.2 Jhonson and Johnson Description and Business Overview 6.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Product Portfolio 6.5.5 Jhonson and Johnson Recent Developments/Updates 6.6 Eli Lilly 6.6.1 Eli Lilly Corporation Information 6.6.2 Eli Lilly Description and Business Overview 6.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Eli Lilly Angiotensin Receptor Antagonists Product Portfolio 6.6.5 Eli Lilly Recent Developments/Updates 6.7 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Angiotensin Receptor Antagonists Product Portfolio 6.7.5 Sanofi Recent Developments/Updates 6.8 Bristol-Myers Squibb 6.8.1 Bristol-Myers Squibb Corporation Information 6.8.2 Bristol-Myers Squibb Description and Business Overview 6.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Portfolio 6.8.5 Bristol-Myers Squibb Recent Developments/Updates 6.9 Bayer 6.9.1 Bayer Corporation Information 6.9.2 Bayer Description and Business Overview 6.9.3 Bayer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Bayer Angiotensin Receptor Antagonists Product Portfolio 6.9.5 Bayer Recent Developments/Updates 6.10 GSK 6.10.1 GSK Corporation Information 6.10.2 GSK Description and Business Overview 6.10.3 GSK Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.10.4 GSK Angiotensin Receptor Antagonists Product Portfolio 6.10.5 GSK Recent Developments/Updates 6.11 Teva Pharmaceutical 6.11.1 Teva Pharmaceutical Corporation Information 6.11.2 Teva Pharmaceutical Angiotensin Receptor Antagonists Description and Business Overview 6.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Product Portfolio 6.11.5 Teva Pharmaceutical Recent Developments/Updates 7 Angiotensin Receptor Antagonists Manufacturing Cost Analysis 7.1 Angiotensin Receptor Antagonists Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Angiotensin Receptor Antagonists 7.4 Angiotensin Receptor Antagonists Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Angiotensin Receptor Antagonists Distributors List 8.3 Angiotensin Receptor Antagonists Customers 9 Angiotensin Receptor Antagonists Market Dynamics 9.1 Angiotensin Receptor Antagonists Industry Trends 9.2 Angiotensin Receptor Antagonists Growth Drivers 9.3 Angiotensin Receptor Antagonists Market Challenges 9.4 Angiotensin Receptor Antagonists Market Restraints 10 Global Market Forecast 10.1 Angiotensin Receptor Antagonists Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Angiotensin Receptor Antagonists by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Angiotensin Receptor Antagonists by Type (2022-2027) 10.2 Angiotensin Receptor Antagonists Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Angiotensin Receptor Antagonists by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Angiotensin Receptor Antagonists by Application (2022-2027) 10.3 Angiotensin Receptor Antagonists Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Angiotensin Receptor Antagonists by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Angiotensin Receptor Antagonists by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Angiotensin Receptor Antagonists Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Angiotensin Receptor Antagonists Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Angiotensin Receptor Antagonists Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Angiotensin Receptor Antagonists Covered in This Study Table 5. Global Angiotensin Receptor Antagonists Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Angiotensin Receptor Antagonists Sales Market Share by Manufacturers (2016-2021) Table 7. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Angiotensin Receptor Antagonists Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Angiotensin Receptor Antagonists Manufacturing Sites and Area Served Table 11. Manufacturers Angiotensin Receptor Antagonists Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Antagonists as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Angiotensin Receptor Antagonists Sales by Region (2016-2021) & (K Units) Table 16. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2016-2021) Table 17. Global Angiotensin Receptor Antagonists Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Angiotensin Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 19. North America Angiotensin Receptor Antagonists Sales Market Share by Country (2016-2021) Table 20. North America Angiotensin Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Angiotensin Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 22. Europe Angiotensin Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 23. Europe Angiotensin Receptor Antagonists Sales Market Share by Country (2016-2021) Table 24. Europe Angiotensin Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Angiotensin Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Angiotensin Receptor Antagonists Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Angiotensin Receptor Antagonists Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Angiotensin Receptor Antagonists Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Angiotensin Receptor Antagonists Revenue Market Share by Region (2016-2021) Table 30. Latin America Angiotensin Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 31. Latin America Angiotensin Receptor Antagonists Sales Market Share by Country (2016-2021) Table 32. Latin America Angiotensin Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Angiotensin Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Angiotensin Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Angiotensin Receptor Antagonists Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Angiotensin Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Angiotensin Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 38. Global Angiotensin Receptor Antagonists Sales (K Units) by Type (2016-2021) Table 39. Global Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021) Table 40. Global Angiotensin Receptor Antagonists Revenue (Million US$) by Type (2016-2021) Table 41. Global Angiotensin Receptor Antagonists Revenue Share by Type (2016-2021) Table 42. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Type (2016-2021) Table 43. Global Angiotensin Receptor Antagonists Sales (K Units) by Application (2016-2021) Table 44. Global Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021) Table 45. Global Angiotensin Receptor Antagonists Revenue (Million US$) by Application (2016-2021) Table 46. Global Angiotensin Receptor Antagonists Revenue Share by Application (2016-2021) Table 47. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Angiotensin Receptor Antagonists Product Table 52. Pfizer Recent Developments/Updates Table 53. Novartis Corporation Information Table 54. Novartis Description and Business Overview Table 55. Novartis Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Novartis Angiotensin Receptor Antagonists Product Table 57. Novartis Recent Developments/Updates Table 58. Merck Corporation Information Table 59. Merck Description and Business Overview Table 60. Merck Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Merck Angiotensin Receptor Antagonists Product Table 62. Merck Recent Developments/Updates Table 63. Astra Zeneca Corporation Information Table 64. Astra Zeneca Description and Business Overview Table 65. Astra Zeneca Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Astra Zeneca Angiotensin Receptor Antagonists Product Table 67. Astra Zeneca Recent Developments/Updates Table 68. Jhonson and Johnson Corporation Information Table 69. Jhonson and Johnson Description and Business Overview Table 70. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Jhonson and Johnson Angiotensin Receptor Antagonists Product Table 72. Jhonson and Johnson Recent Developments/Updates Table 73. Eli Lilly Corporation Information Table 74. Eli Lilly Description and Business Overview Table 75. Eli Lilly Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Eli Lilly Angiotensin Receptor Antagonists Product Table 77. Eli Lilly Recent Developments/Updates Table 78. Sanofi Corporation Information Table 79. Sanofi Description and Business Overview Table 80. Sanofi Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi Angiotensin Receptor Antagonists Product Table 82. Sanofi Recent Developments/Updates Table 83. Bristol-Myers Squibb Corporation Information Table 84. Bristol-Myers Squibb Description and Business Overview Table 85. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product Table 87. Bristol-Myers Squibb Recent Developments/Updates Table 88. Bayer Corporation Information Table 89. Bayer Description and Business Overview Table 90. Bayer Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Bayer Angiotensin Receptor Antagonists Product Table 92. Bayer Recent Developments/Updates Table 93. GSK Corporation Information Table 94. GSK Description and Business Overview Table 95. GSK Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. GSK Angiotensin Receptor Antagonists Product Table 97. GSK Recent Developments/Updates Table 98. Teva Pharmaceutical Corporation Information Table 99. Teva Pharmaceutical Description and Business Overview Table 100. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Teva Pharmaceutical Angiotensin Receptor Antagonists Product Table 102. Teva Pharmaceutical Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Angiotensin Receptor Antagonists Distributors List Table 106. Angiotensin Receptor Antagonists Customers List Table 107. Angiotensin Receptor Antagonists Market Trends Table 108. Angiotensin Receptor Antagonists Growth Drivers Table 109. Angiotensin Receptor Antagonists Market Challenges Table 110. Angiotensin Receptor Antagonists Market Restraints Table 111. Global Angiotensin Receptor Antagonists Sales Forecast by Type (2022-2027) & (K Units) Table 112. Global Angiotensin Receptor Antagonists Sales Market Share Forecast by Type (2022-2027) Table 113. Global Angiotensin Receptor Antagonists Revenue Forecast by Type (2022-2027) & (US$ Million) Table 114. Global Angiotensin Receptor Antagonists Revenue Market Share Forecast by Type (2022-2027) Table 115. Global Angiotensin Receptor Antagonists Sales Forecast by Application (2022-2027) & (K Units) Table 116. Global Angiotensin Receptor Antagonists Sales Market Share Forecast by Application (2022-2027) Table 117. Global Angiotensin Receptor Antagonists Revenue Forecast by Application (2022-2027) & (US$ Million) Table 118. Global Angiotensin Receptor Antagonists Revenue Market Share Forecast by Application (2022-2027) Table 119. Global Angiotensin Receptor Antagonists Sales Forecast by Region (2022-2027) & (K Units) Table 120. Global Angiotensin Receptor Antagonists Sales Market Share Forecast by Region (2022-2027) Table 121. Global Angiotensin Receptor Antagonists Revenue Forecast by Region (2022-2027) & (US$ Million) Table 122. Global Angiotensin Receptor Antagonists Revenue Market Share Forecast by Region (2022-2027) Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Angiotensin Receptor Antagonists Figure 2. Global Angiotensin Receptor Antagonists Market Share by Type in 2020 & 2027 Figure 3. Valsartan Product Picture Figure 4. Telmisartan Product Picture Figure 5. Losartan Product Picture Figure 6. Irbesartan Product Picture Figure 7. Azilsartan Product Picture Figure 8. Olmesartan Product Picture Figure 9. Global Angiotensin Receptor Antagonists Market Share by Application in 2020 & 2027 Figure 10. Hypertension Figure 11. Cardiovascular Diseases Figure 12. Kidney Diseases Figure 13. Other Figure 14. Global Angiotensin Receptor Antagonists Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Angiotensin Receptor Antagonists Market Size 2016-2027 (US$ Million) Figure 16. Global Angiotensin Receptor Antagonists Sales 2016-2027 (K Units) Figure 17. Global Angiotensin Receptor Antagonists Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Angiotensin Receptor Antagonists Sales Share by Manufacturers in 2020 Figure 19. Global Angiotensin Receptor Antagonists Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Angiotensin Receptor Antagonists Players: Market Share by Revenue in 2020 Figure 21. Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2016-2021) Figure 23. Global Angiotensin Receptor Antagonists Sales Market Share by Region in 2020 Figure 24. Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2016-2021) Figure 25. Global Angiotensin Receptor Antagonists Revenue Market Share by Region in 2020 Figure 26. U.S. Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Angiotensin Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Angiotensin Receptor Antagonists by Type (2016-2021) Figure 51. Sales Market Share of Angiotensin Receptor Antagonists by Application (2016-2021) Figure 52. Sales Market Share of Angiotensin Receptor Antagonists by Application in 2020 Figure 53. Revenue Share of Angiotensin Receptor Antagonists by Application (2016-2021) Figure 54. Revenue Share of Angiotensin Receptor Antagonists by Application in 2020 Figure 55. Manufacturing Cost Structure of Angiotensin Receptor Antagonists Figure 56. Manufacturing Process Analysis of Angiotensin Receptor Antagonists Figure 57. Angiotensin Receptor Antagonists Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Pfizer Novartis Merck Astra Zeneca Jhonson and Johnson Eli Lilly Sanofi Bristol-Myers Squibb Bayer GSK Teva Pharmaceutical